Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIONTECH | 7 | 13 | -0,59 % | ||
| MEDPACE | 7 | - | -24,46 % | ||
| ALTIMMUNE | 6 | - | -12,33 % | ||
| AMGEN | 5 | 27 | +0,64 % | ||
| REGENERON PHARMACEUTICALS | 5 | 22 | +1,30 % | ||
| VANDA PHARMACEUTICALS | 3 | - | -0,17 % | ||
| AMNEAL PHARMACEUTICALS | 3 | - | +4,55 % | ||
| INHIBRX BIOSCIENCES | 3 | - | +12,85 % | ||
| NEUROCRINE BIOSCIENCES | 2 | 17 | +1,20 % | ||
| HARMONY BIOSCIENCES | 2 | 17 | -0,22 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16:38 | Eilmeldung am Abend: BIONTECH SE ADR kurz vor Wendepunkt? | 1 | Maximilian Berger | ||
| 16:34 | BDTX Stock: Neutral Zacks Rank, $4 Target, and What Must Go Right | 1 | Zacks | ||
| 16:34 | BDTX and the CNS-Active EGFR Trend: Why C797S Is the Prize | 2 | Zacks | ||
| 16:34 | Mizuho senkt Kursziel für Tarsus Pharmaceuticals wegen Umsatzaussichten auf 100 $ | 2 | Investing.com Deutsch | ||
| 16:30 | Transcript: Medpace Holdings Q1 2026 Earnings Conference Call | 8 | Benzinga.com | ||
| 16:26 | Praxis Precision Medicines (PRAX): One of the Best Upside Stocks | 2 | Insider Monkey | ||
| 16:18 | Piper Sandler reiterates Definium stock rating on development plan | 1 | Investing.com | ||
| 16:10 | Do Options Traders Know Something About Alkermes Stock We Don't? | 2 | Zacks | ||
| 15:42 | Why Is Altimmune Stock Falling Today? | 2 | Benzinga.com | ||
| 15:18 | Sanofi Q1 2026 slides: Dupixent drives double-digit growth | 5 | Investing.com | ||
| 14:36 | Vericel Corporation: Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026 | 1 | GlobeNewswire (USA) | ||
| 14:35 | Viatris' Q1 2026 Earnings: What to Expect | 10 | Barchart.com | ||
| 14:34 | Sanofi Tops Q1 Earnings Estimates as Dupixent & New Drugs Drive Growth | 4 | Zacks | ||
| 14:34 | AMRX Announces Kashiv BioSciences Buyout, Solid Q1 Preliminary Results | 1 | Zacks | ||
| 14:06 | Esperion Therapeutics, Inc.: Esperion to Report First Quarter 2026 Financial Results on May 7 | 1 | GlobeNewswire (USA) | ||
| 14:06 | Ardelyx, Inc.: Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026 | 1 | GlobeNewswire (USA) | ||
| 14:06 | Collegium Pharmaceutical, Inc.: Collegium to Report First Quarter 2026 Financial Results on May 7, 2026 | 4 | GlobeNewswire (USA) | ||
| 14:06 | H.C. Wainwright reiterates Kyverna Therapeutics stock rating at buy | 5 | Investing.com | ||
| 13:54 | Corvus Pharmaceuticals appoints ex-Genentech executive to board | 1 | Investing.com | ||
| 13:52 | ROUNDUP/Vor Chefwechsel: Überraschend starker Jahresstart bei Sanofi | 259 | dpa-AFX | PARIS (dpa-AFX) - Der Pharmakonzern Sanofi ist zum Jahresstart dank seines Kassenschlagers Dupixent, neuer Medikamente und Übernahmen überraschend kräftig gewachsen. Damit verschaffen die Franzosen... ► Artikel lesen |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.